Severe pyoderma following corticosteroid occlusion.
I
I
Kikuchi
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004485:Eczema / Q000175:diagnosis / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D007564:Japan; D035002:Lower Extremity; D008297:Male; D009824:Ointments; D011711:Pyoderma / Q000139:chemically induced* / Q000503:physiopathology; D018570:Risk Assessment; D012720:Severity of Illness Index; D013211:Staphylococcus aureus / Q000302:isolation & purification*
D000305:Adrenal Cortex Hormones; D009824:Ointments